Aug 04, 2022 / 11:30AM GMT
Operator
Hello, everybody, and welcome to the Pharming's First Half of 2022 Results Call. My name is Sam, and I'll be coordinating your call today. (Operator Instructions)
I will now hand you over to your host, Sijmen de Vries, the CEO of Pharming to begin. Sijmen, please go ahead.
Sijmen de Vries - Pharming Group N.V. - President, CEO & Executive Director
Thank you very much, Sam. Good morning or good afternoon, ladies and gentlemen. I'm very pleased to bring you the first half results for 2022 today.
Before I do that, I would like to draw your attention to Slide #2, the forward-looking statement slide, because this presentation may contain forward-looking statements. And as you know, forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based upon our current beliefs, expectations and assumptions regarding the future of our business future plans, our strategies, our development plans, our clinical results and other future conditions. So please take note of that.
And then I would
Q2 2022 Pharming Group NV Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
